{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:21:54Z","timestamp":1787440914280,"version":"build-2736575974"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL148711"],"award-info":[{"award-number":["R01HL148711"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119610","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:59:55Z","timestamp":1780916395000},"page":"119610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nicotine-associated cardiovascular dysfunction: From pharmacological insights to emerging therapeutic interventions"],"prefix":"10.1016","volume":"200","author":[{"given":"Mohammad Atiqur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Areeful","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saisudha","family":"Koka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna M.","family":"Boini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.toxicon.2004.01.017","article-title":"Nicotine, its metabolism and an overview of its biological effects","volume":"43","author":"Yildiz","year":"2004","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"01","key":"10.1016\/j.biopha.2026.119610_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0971-5851.151771","article-title":"Harmful effects of nicotine","volume":"36","author":"Mishra","year":"2015","journal-title":"Indian. J. Med. Paediatr. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/clpt.1984.142","article-title":"Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking","volume":"36","author":"Benowitz","year":"1984","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119610_bib5","first-page":"827","article-title":"Tobacco reborn: the rise of e-cigarettes and regulatory approaches","volume":"25","author":"Aaron","year":"2021","journal-title":"Lewis Clark L. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib6","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.21037\/tlcr.2019.03.13","article-title":"Tobacco and electronic nicotine delivery systems regulation","volume":"8","author":"Stone","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/tobaccocontrol-2021-056544","article-title":"Evolution of tobacco products: recent history and future directions","volume":"31","author":"Connor","year":"2022","journal-title":"Tob. Control."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5334\/gh.1292","article-title":"Nicotine and cardiovascular health: when poison is addictive\u2013a WHF policy brief","volume":"19","author":"Dorotheo","year":"2024","journal-title":"Glob. Heart"},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tcm.2016.03.001","article-title":"Cardiovascular toxicity of nicotine: implications for electronic cigarette use","volume":"26","author":"Benowitz","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2026.119610_bib10","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/jcph.1915","article-title":"Clinical pharmacology of electronic nicotine delivery systems (ENDS): implications for benefits and risks in the promotion of the combusted tobacco endgame","volume":"61","author":"Benowitz","year":"2021","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119610_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006353","article-title":"Impact of electronic cigarettes on the cardiovascular system","volume":"6","author":"Qasim","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","article-title":"Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis","volume":"129","author":"Mills","year":"2014","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.biopha.2026.119610_bib13","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMra1502466","article-title":"The health effects of electronic cigarettes","volume":"375","author":"Dinakar","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ntr\/ntw160","article-title":"Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study","volume":"19","author":"Goniewicz","year":"2017","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.biopha.2026.119610_bib15","unstructured":"W.H. Organization, WHO report on the global tobacco epidemic 2021: addressing new and emerging products, 2021."},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib16","first-page":"663","article-title":"Vaping epidemic: challenges and opportunities","volume":"31","author":"Besaratinia","year":"2020","journal-title":"Cancer Causes Control."},{"key":"10.1016\/j.biopha.2026.119610_bib17","article-title":"Notes from the field: E-cigarette use among middle and high school students\u2014United States, 2022, MMWR","volume":"71","author":"Cooper","year":"2022","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.biopha.2026.119610_bib18","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7244a1","article-title":"Tobacco product use among US middle and high school students\u2014National Youth Tobacco Survey, 2023","volume":"72","author":"Birdsey","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.biopha.2026.119610_bib19","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.12688\/f1000research.20062.2","article-title":"Cardiovascular, carcinogenic and reproductive effects of nicotine exposure: a narrative review of the scientific literature","volume":"8","author":"Price","year":"2020","journal-title":"F1000Research"},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbrc.2006.08.115","article-title":"Involvement of DDAH\/ADMA\/NOS pathway in nicotine-induced endothelial dysfunction","volume":"349","author":"Jiang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2026.119610_bib21","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1111\/jcmm.13812","article-title":"Nicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH 1","volume":"22","author":"Li","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119610_bib22","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.2147\/DMSO.S329675","article-title":"Metabolic syndrome associated with tobacco and caffeine products use among refugee adolescents: risk of dyslipidemia","author":"Damiri","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.hrthm.2022.09.021","article-title":"Increased vulnerability to atrial and ventricular arrhythmias caused by different types of inhaled tobacco or marijuana products","volume":"20","author":"Qiu","year":"2023","journal-title":"Heart Rhythm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41419-017-0257-3","article-title":"Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis","volume":"9","author":"Wu","year":"2018","journal-title":"Cell. Death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/biomedicines13020416","article-title":"Acid sphingomyelinase and ceramide signaling pathway mediates nicotine-induced NLRP3 inflammasome activation and podocyte injury","volume":"13","author":"Rahman","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119610_bib26","unstructured":"A.B. Irfan, The effects of nicotine and cigarette smoking on cardiac electrophysiology, 2019."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41598-022-05108-y","article-title":"A comprehensive physiologically based pharmacokinetic (PBPK) model for nicotine in humans from using nicotine-containing products with different routes of exposure","volume":"12","author":"Rostami","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/acs.chemrestox.2c00310","article-title":"A systematic review of analytical methods for the separation of nicotine enantiomers and evaluation of nicotine sources","volume":"36","author":"Salam","year":"2023","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/aps.2009.37","article-title":"Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance","volume":"30","author":"Bencherif","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2026.119610_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108256","article-title":"Nicotinic acetylcholine receptors and nicotine addiction: a brief introduction","volume":"177","author":"Wittenberg","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119610_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40262-020-00960-5","article-title":"Nicotine population pharmacokinetics in healthy smokers after intravenous, oral, buccal and transdermal administration: POO Gisleskog et al.","volume":"60","author":"Olsson Gisleskog","year":"2021","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ajpath.2020.11.007","article-title":"Effects of electronic nicotine delivery systems and cigarettes on systemic circulation and blood-brain barrier: implications for cognitive decline","volume":"191","author":"Heldt","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib33","first-page":"143","article-title":"Pharmacokinetics and metabolism of nicotine","volume":"57","author":"Tutka","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2026.119610_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108021","article-title":"Nicotinic acetylcholine receptors: conventional and unconventional ligands and signaling","volume":"168","author":"Papke","year":"2020","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.biopha.2026.119610_bib35","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.3390\/ijms25042304","article-title":"Nicotinic receptors in human chromaffin cells: characterization, functional and physical interactions between subtypes and regulation","volume":"25","author":"Jim\u00e9nez-Pompa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119610_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106764","article-title":"Nicotinic acetylcholine receptors in neurological and psychiatric diseases","volume":"191","author":"Terry","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2026.119610_bib37","series-title":"Nicotine, Caffeine and Social Drinking: Behaviour and Brain Function","first-page":"3","article-title":"Pharmacokinetics and pharmacodynamics of nicotine","author":"Houezec","year":"2013"},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib38","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.52711\/0974-360X.2024.00407","article-title":"Nicotine and neurotransmitters an update","volume":"17","author":"Soni","year":"2024","journal-title":"Res. J. Pharm. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/biomedicines10010121","article-title":"Influence of nicotine from diverse delivery tools on the autonomic nervous and hormonal systems","volume":"10","author":"Menshov","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.biopha.2026.119610_bib40","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/antiox11101958","article-title":"Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease","volume":"11","author":"Higashi","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib41","article-title":"Nicotinic acetylcholine receptors in cancer: limitations and prospects","volume":"1870","author":"Bele","year":"2024","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.biopha.2026.119610_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13631","article-title":"Nicotine and vascular dysfunction","volume":"231","author":"Whitehead","year":"2021","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib43","first-page":"1","article-title":"Literature review on nicotine\u2019s role in human health","volume":"34","author":"Scherer","year":"2024","journal-title":"Contrib. Tob. Nicotine Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119610_bib44","doi-asserted-by":"crossref","first-page":"R895","DOI":"10.1152\/ajpregu.00099.2018","article-title":"Nicotine and the renin-angiotensin system","volume":"315","author":"Oakes","year":"2018","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2026.119610_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.879726","article-title":"Electronic cigarette use and the risk of cardiovascular diseases","volume":"9","author":"Espinoza-Derout","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.biopha.2026.119610_bib46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/antiox13111395","article-title":"The hidden dangers: e-cigarettes, heated tobacco, and their impact on oxidative stress and atherosclerosis\u2014a systematic review and narrative synthesis of the evidence","volume":"13","author":"Magna","year":"2024","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib47","doi-asserted-by":"crossref","first-page":"F442","DOI":"10.1152\/ajprenal.00194.2020","article-title":"Nicotine, smoking, podocytes, and diabetic nephropathy","volume":"320","author":"Jaimes","year":"2021","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib48","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/ijms26031204","article-title":"Advances in the regulation of inflammatory mediators in nitric oxide synthase: implications for disease modulation and therapeutic approaches","volume":"26","author":"Kim","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib49","doi-asserted-by":"crossref","first-page":"L175","DOI":"10.1152\/ajplung.00411.2014","article-title":"Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures","volume":"309","author":"Schweitzer","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib50","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ntr\/ntac019","article-title":"Comparable impairment of vascular endothelial function by a wide range of electronic nicotine delivery devices","volume":"24","author":"Rao","year":"2022","journal-title":"Nicotine Tob. Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119610_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13050583","article-title":"Radical oxygen species, oxidized low-density lipoproteins, and lectin-like oxidized low-density lipoprotein receptor 1: a vicious circle in atherosclerotic process","volume":"13","author":"Munno","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119610_bib52","series-title":"Endotext, MDText.com, Inc. Copyright \u00a9 2000\u20132025","article-title":"ThE Role of Lipids and Lipoproteins in Atherosclerosis","author":"Linton","year":"2000"},{"key":"10.1016\/j.biopha.2026.119610_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112784","article-title":"The roles and regulatory mechanisms of cigarette smoke constituents in vascular remodeling","volume":"140","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1573403X18666220411113112","article-title":"Pathophysiologic mechanisms of tobacco smoke producing atherosclerosis","volume":"18","author":"Klein","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2026.119610_bib55","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/CIRCULATIONAHA.105.535294","article-title":"Role of angiogenesis in cardiovascular disease: a critical appraisal","volume":"112","author":"Khurana","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11020350","article-title":"Effects of exercise training on the autonomic nervous system with a focus on anti-inflammatory and antioxidants effects","volume":"11","author":"Daniela","year":"2022","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.biopha.2026.119610_bib57","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40885-023-00258-1","article-title":"Arterial stiffness and hypertension","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Hypertens."},{"issue":"10","key":"10.1016\/j.biopha.2026.119610_bib59","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/01.CIR.102.10.1165","article-title":"Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4.3 channels and native transient outward current","volume":"102","author":"Wang","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40001-025-02302-2","article-title":"Myocardial ferroptosis may exacerbate the progression of atrial fibrillation through isolevuglandins","volume":"30","author":"Yue","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.biopha.2026.119610_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.650055","article-title":"Nicotine causes mitochondrial dynamics imbalance and apoptosis through ROS mediated mitophagy impairment in cardiomyocytes","volume":"12","author":"Meng","year":"2021","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib62","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1165\/rcmb.2020-0504OC","article-title":"Connective-tissue growth factor contributes to TGF-\u03b21\u2013induced lung fibrosis","volume":"66","author":"Yanagihara","year":"2022","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119610_bib63","unstructured":"C. Centers for Disease, Prevention, P. National Center for Chronic Disease, P. Health, S. Office on, Health, Publications and Reports of the Surgeon General, How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General, Centers for Disease Control and Prevention (US), Atlanta (GA), 2010."},{"key":"10.1016\/j.biopha.2026.119610_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/cells13070581","article-title":"NF-\u03baB and JAK\/STAT signaling pathways as crucial regulators of neuroinflammation and astrocyte modulation in spinal cord injury","volume":"13","author":"Ageeva","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib67","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.3390\/ijerph19063237","article-title":"Acute effects of electronic and tobacco cigarette smoking on sympathetic nerve activity and blood pressure in humans","volume":"19","author":"Dimitriadis","year":"2022","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"4","key":"10.1016\/j.biopha.2026.119610_bib68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/toxics8040092","article-title":"Nicotine causes nephrotoxicity through the induction of nlrp6 inflammasome and alpha7 nicotinic acetylcholine receptor","volume":"8","author":"Zheng","year":"2020","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","article-title":"Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases","volume":"24","author":"Warda","year":"2025","journal-title":"Lipids Health Dis."},{"issue":"13","key":"10.1016\/j.biopha.2026.119610_bib70","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/cells12131766","article-title":"Inflammasomes: mechanisms of action and involvement in human diseases","volume":"12","author":"Bult\u00e9","year":"2023","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.biopha.2026.119610_bib71","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/antiox12091732","article-title":"Cigarette smoke-induced reactive oxygen species formation: a concise review","volume":"12","author":"Seo","year":"2023","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib72","doi-asserted-by":"crossref","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-\u03b2 signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib73","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/en.2017-00594","article-title":"\u03b1 7-nicotinic acetylcholine receptor agonist ameliorates nicotine plus high-fat diet\u2013induced hepatic steatosis in male mice by inhibiting oxidative stress and stimulating AMPK signaling","volume":"159","author":"Hasan","year":"2018","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.biopha.2026.119610_bib74","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Boren","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2026.119610_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117095","article-title":"Chronic exposure to E-cigarette aerosols potentiates atherosclerosis in a sex-dependent manner","volume":"492","author":"Caruana","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119610_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnesp.2025.01.026","article-title":"Combined action of dietary-based approaches and therapeutic agents on cholesterol metabolism and main related diseases","author":"Baptista","year":"2025","journal-title":"Clin. Nutr. ESPEN"},{"issue":"12","key":"10.1016\/j.biopha.2026.119610_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003410","article-title":"Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: a multivariable Mendelian randomization study","volume":"17","author":"Rosoff","year":"2020","journal-title":"PLoS. Med."},{"issue":"10","key":"10.1016\/j.biopha.2026.119610_bib78","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1210\/en.2015-2057","article-title":"Activation of nicotinic acetylcholine receptors decreases apoptosis in human and female murine pancreatic islets","volume":"157","author":"Klee","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib80","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jacc.2017.05.043","article-title":"Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: Part 3 of a 3-part series","volume":"70","author":"Niemann","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.biopha.2026.119610_bib81","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","article-title":"Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis","volume":"29","author":"Pal","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib82","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13098-019-0482-2","article-title":"Smoking and diabetes: dangerous liaisons and confusing relationships","volume":"11","author":"Campagna","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"issue":"13","key":"10.1016\/j.biopha.2026.119610_bib83","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib84","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37936","article-title":"Analysis of active and passive tobacco exposures and blood pressure in US children and adolescents","volume":"4","author":"Levy","year":"2021","journal-title":"JAMA Netw. Open."},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib85","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00213-021-05791-1","article-title":"Synergistic antihyperalgesic and antinociceptive effects of morphine and methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (MP-III-024): a positive allosteric modulator at \u03b12GABA(A) and \u03b13GABA(A) receptors","volume":"238","author":"Rahman","year":"2021","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib86","article-title":"Pharmacotherapy in tobacco cessation: a narrative review","volume":"15","author":"Pajai","year":"2023","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.biopha.2026.119610_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay9763","article-title":"Current advances in research in treatment and recovery: nicotine addiction","volume":"5","author":"Prochaska","year":"2019","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.biopha.2026.119610_bib88","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1521-0391.2013.12037.x","article-title":"Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction?","volume":"22","author":"Nocente","year":"2013","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib89","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/add.13604","article-title":"Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model","volume":"112","author":"Mathew","year":"2017","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.biopha.2026.119610_bib90","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.bcp.2007.07.034","article-title":"Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area","volume":"74","author":"Mansvelder","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119610_bib91","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.neuropharm.2011.07.009","article-title":"Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors","volume":"61","author":"Garc\u00eda-Colunga","year":"2011","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.biopha.2026.119610_bib92","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/appi.ajp.2014.13050595","article-title":"Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm","volume":"171","author":"Rose","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12889-015-2055-0","article-title":"Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Chang","year":"2015","journal-title":"BMC Public Health"},{"issue":"10037","key":"10.1016\/j.biopha.2026.119610_bib94","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2026.119610_bib95","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jamainternmed.2018.0397","article-title":"Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial","volume":"178","author":"Benowitz","year":"2018","journal-title":"JAMA Intern. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10571-020-00846-x","article-title":"Nicotinic acetylcholine receptors of PC12 cells","volume":"41","author":"Mussina","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119610_bib97","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/iub.2117","article-title":"Cholinergic and peptidergic neurotransmission in the adrenal medulla: a dynamic control of stimulus-secretion coupling","volume":"72","author":"Gu\u00e9rineau","year":"2020","journal-title":"IUBMB Life"},{"issue":"10226","key":"10.1016\/j.biopha.2026.119610_bib98","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155,722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.biopha.2026.119610_bib99","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038560","article-title":"Dependable approaches to hypertension management: a review","volume":"103","author":"Elendu","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2026.119610_bib100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3389\/fphar.2019.01493","article-title":"Angiotensin II type I receptor antagonism attenuates nicotine-induced cardiac remodeling, dysfunction, and aggravation of myocardial ischemia-reperfusion injury in rats","volume":"10","author":"Ramalingam","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib101","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/SAP.0b013e3182367be1","article-title":"Calcium channel blockers reduce the effects of cigarette smoking on peripheral nerve ischemia\/reperfusion injury","volume":"70","author":"Rinker","year":"2013","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.biopha.2026.119610_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.841545","article-title":"Modified lipoproteins induce arterial wall inflammation during atherogenesis","volume":"9","author":"Lorey","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib103","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/pharmaceutics16020214","article-title":"Potential benefits and risks associated with the use of statins","volume":"16","author":"Khatiwada","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119610_bib105","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1194\/jlr.M700345-JLR200","article-title":"Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse","volume":"48","author":"Valasek","year":"2007","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib106","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4093\/dmj.2023.0168","article-title":"Role of fenofibrate use in dyslipidemia and related comorbidities in the Asian population: a narrative review","volume":"48","author":"Deerochanawong","year":"2024","journal-title":"Diabetes Metab. J."},{"issue":"18","key":"10.1016\/j.biopha.2026.119610_bib107","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.biopha.2026.119610_bib108","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10193","key":"10.1016\/j.biopha.2026.119610_bib109","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2026.119610_bib110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5(5)","key":"10.1016\/j.biopha.2026.119610_bib111","doi-asserted-by":"crossref","first-page":"771","DOI":"10.34067\/KID.0000000000000425","article-title":"SGLT2 inhibitors and kidney protection: mechanisms beyond tubuloglomerular feedback","volume":"360","author":"Upadhyay","year":"2024","journal-title":"Kidney"},{"issue":"16","key":"10.1016\/j.biopha.2026.119610_bib112","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2020.02.056","article-title":"Diabetic agents, from metformin to SGLT2 inhibitors and GLP1 receptor agonists: JACC focus seminar","volume":"75","author":"Wilcox","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2026.119610_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119610_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib116","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib117","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","article-title":"Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950","volume":"73","author":"Corcoran","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"10118","key":"10.1016\/j.biopha.2026.119610_bib118","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.biopha.2026.119610_bib119","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4330\/wjc.v16.i12.707","article-title":"E-cigarettes and arterial health: A review of the link between vaping and atherosclerosis progression","volume":"16","author":"Hassan","year":"2024","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.biopha.2026.119610_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.981838","article-title":"Cardiovascular effects of immunosuppression agents","volume":"9","author":"Elezaby","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"8","key":"10.1016\/j.biopha.2026.119610_bib121","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/nu13082830","article-title":"Multifactorial basis and therapeutic strategies in metabolism-related diseases","volume":"13","author":"Guerra","year":"2021","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.biopha.2026.119610_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/cells13231946","article-title":"High mobility group box 1 (HMGB1): molecular signaling and potential therapeutic strategies","volume":"13","author":"Datta","year":"2024","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib123","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2011.06.033","article-title":"Cross talk between mitochondria and NADPH oxidases","volume":"51","author":"Dikalov","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"20","key":"10.1016\/j.biopha.2026.119610_bib124","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.3390\/ijms242015160","article-title":"New dawn for atherosclerosis: vascular endothelial cell senescence and death","volume":"24","author":"Bu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib125","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3390\/antiox12071316","article-title":"N-acetylcysteine pharmacology and applications in rare diseases\u2014repurposing an old antioxidant","volume":"12","author":"Sahasrabudhe","year":"2023","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib126","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/antiox12061210","article-title":"Cigarette smoke-induced respiratory response: insights into cellular processes and biomarkers","volume":"12","author":"Cha","year":"2023","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib127","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3390\/antiox14030256","article-title":"Endothelial dysfunction: redox imbalance, NLRP3 inflammasome, and inflammatory responses in cardiovascular diseases","volume":"14","author":"Penna","year":"2025","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib128","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030303","article-title":"Mitochondria-targeted antioxidant therapeutics for traumatic brain injury","volume":"13","author":"Modi","year":"2024","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib129","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119610_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/biology10010018","article-title":"Oxidative stress and inflammation in renal and cardiovascular complications of diabetes","volume":"10","author":"Charlton","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2026.119610_bib131","article-title":"Setanaxib (GKT137831) ameliorates doxorubicin-induced cardiotoxicity by inhibiting the NOX1\/NOX4\/reactive oxygen species\/MAPK pathway","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.biopha.2026.119610_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168590","article-title":"Insulin signal transduction perturbations in insulin resistance","volume":"22","author":"Khalid","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib133","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.taap.2012.09.009","article-title":"Cadmium-induced oxidative stress and histological damage in the myocardium. Effects of a soy-based diet","volume":"265","author":"Ferramola","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119610_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020122","article-title":"The current and potential therapeutic use of metformin\u2013the good old drug","volume":"14","author":"Drzewoski","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"19","key":"10.1016\/j.biopha.2026.119610_bib135","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.7150\/thno.64706","article-title":"Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function","volume":"11","author":"Ding","year":"2021","journal-title":"Theranostics"},{"issue":"15","key":"10.1016\/j.biopha.2026.119610_bib136","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119610_bib137","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nm.3214","article-title":"Acid sphingomyelinase\u2013ceramide system mediates effects of antidepressant drugs","volume":"19","author":"Gulbins","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119610_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118110","article-title":"Mitigation of nicotine-induced podocyte injury through inhibition of thioredoxin interacting protein","volume":"187","author":"Datta","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2026.119610_bib139","first-page":"56","article-title":"Role of sphingolipid signaling in glomerular diseases: focus on DKD and FSGS","volume":"1","author":"Mitrofanova","year":"2020","journal-title":"J. Cell Signal."},{"key":"10.1016\/j.biopha.2026.119610_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720049","article-title":"Roles of inflammasome in cigarette smoke-related diseases and physiopathological disorders: mechanisms and therapeutic opportunities","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119610_bib141","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bbamem.2007.03.026","article-title":"Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies","volume":"1768","author":"Zidovetzki","year":"2007","journal-title":"Biochim. et Biophys. Acta (BBA) - Biomembr."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:41:49Z","timestamp":1787438509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":141,"alternative-id":["S0753332226006463"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119610","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotine-associated cardiovascular dysfunction: From pharmacological insights to emerging therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119610"}}